These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 27518753)

  • 41. Rectal artesunates, their utilization, and parental perception in the management of malaria in children from Abeokuta, southwestern Nigeria.
    Sam-Wobo SO; Agbeyangi OA; Ekpo UF; Akinloye OA; Mafiana CF; Adeleke MA
    Vector Borne Zoonotic Dis; 2012 Feb; 12(2):151-5. PubMed ID: 22022814
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania.
    Mårtensson A; Strömberg J; Sisowath C; Msellem MI; Gil JP; Montgomery SM; Olliaro P; Ali AS; Björkman A
    Clin Infect Dis; 2005 Oct; 41(8):1079-86. PubMed ID: 16163624
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Artesunate plus sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum malaria in Sudan.
    Elamin SB; Malik EM; Abdelgadir T; Khamiss AH; Mohammed MM; Ahmed ES; Adam I
    Malar J; 2005 Sep; 4():41. PubMed ID: 16162284
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Artesunate with mefloquine at various intervals for non-severe Plasmodium falciparum malaria.
    Hung le Q; de Vries PJ; Binh TQ; Giao PT; Nam NV; Holman R; Kager PA
    Am J Trop Med Hyg; 2004 Aug; 71(2):160-6. PubMed ID: 15306704
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Resistance-mediating Plasmodium falciparum pfcrt and pfmdr1 alleles after treatment with artesunate-amodiaquine in Uganda.
    Nsobya SL; Dokomajilar C; Joloba M; Dorsey G; Rosenthal PJ
    Antimicrob Agents Chemother; 2007 Aug; 51(8):3023-5. PubMed ID: 17562798
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of artesunate and quinine in the treatment of severe Plasmodium falciparum malaria at Kassala hospital, Sudan.
    Abdallah TM; Elmardi KA; Elhassan AH; Omer MB; Elhag MS; Desogi MA; Siddig MF; Adam I
    J Infect Dev Ctries; 2014 May; 8(5):611-5. PubMed ID: 24820465
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Failure of intravenous artesunate treatment for Plasmodium falciparum malaria in a splenectomized traveller: A diagnostic challenge.
    Marco-Hernández J; Camprubí D; Aylagas C; Gupta H; Castro P
    Travel Med Infect Dis; 2019; 30():142-143. PubMed ID: 30227244
    [No Abstract]   [Full Text] [Related]  

  • 48. Malaria resistance to non-artemisinin partner drugs: how to reACT.
    van Schalkwyk DA; Sutherland CJ
    Lancet Infect Dis; 2015 Jun; 15(6):621-3. PubMed ID: 25877961
    [No Abstract]   [Full Text] [Related]  

  • 49. Imported quinine resistant Plasmodium falciparum malaria in Sri Lanka.
    Wijesundere A; Karunanayake P; Athukorala I; Jayasekara K
    Ceylon Med J; 2005 Sep; 50(3):125-6. PubMed ID: 16252578
    [No Abstract]   [Full Text] [Related]  

  • 50. Waking the sleeping beauty.
    Nosten F
    J Infect Dis; 2010 Nov; 202(9):1300-1. PubMed ID: 20863226
    [No Abstract]   [Full Text] [Related]  

  • 51. Plasmodium falciparum ATP6 not under selection during introduction of artemisinin combination therapy in Peru.
    Woodrow CJ; Bustamante LY
    Antimicrob Agents Chemother; 2010 May; 54(5):2280; author reply 2280-1. PubMed ID: 20404129
    [No Abstract]   [Full Text] [Related]  

  • 52. Suspected
    Nkwabong E; Tseunwo C; Nkene Mawamba Y
    Trop Doct; 2021 Oct; 51(4):626-627. PubMed ID: 34102929
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Slow parasite clearance rates in response to artemether in patients with severe malaria.
    Amaratunga C; Mao S; Sreng S; Suon S; Fairhurst RM
    Lancet Infect Dis; 2013 Feb; 13(2):113-4. PubMed ID: 23347631
    [No Abstract]   [Full Text] [Related]  

  • 54. Artemisinin resistance or artemisinin-based combination therapy resistance?
    Wongsrichanalai C
    Lancet Infect Dis; 2013 Feb; 13(2):114-5. PubMed ID: 23347632
    [No Abstract]   [Full Text] [Related]  

  • 55. Predicting the clinical outcome of severe falciparum malaria in african children: findings from a large randomized trial.
    von Seidlein L; Olaosebikan R; Hendriksen IC; Lee SJ; Adedoyin OT; Agbenyega T; Nguah SB; Bojang K; Deen JL; Evans J; Fanello CI; Gomes E; Pedro AJ; Kahabuka C; Karema C; Kivaya E; Maitland K; Mokuolu OA; Mtove G; Mwanga-Amumpaire J; Nadjm B; Nansumba M; Ngum WP; Onyamboko MA; Reyburn H; Sakulthaew T; Silamut K; Tshefu AK; Umulisa N; Gesase S; Day NP; White NJ; Dondorp AM
    Clin Infect Dis; 2012 Apr; 54(8):1080-90. PubMed ID: 22412067
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Falsified antimalarials: a minireview.
    Chaccour C; Kaur H; Del Pozo JL
    Expert Rev Anti Infect Ther; 2015 Apr; 13(4):505-9. PubMed ID: 25683870
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Malaria: blood slides under treatment.
    Shah PM
    Int J Infect Dis; 2003 Sep; 7(3):233; author reply 233. PubMed ID: 14563229
    [No Abstract]   [Full Text] [Related]  

  • 58. US Department of Defense contributions to malaria surveillance.
    Saunders D; Duplessis C; Lescano A; Andagalu B; Thomas A; Fukuda M; Cummings J;
    Lancet Infect Dis; 2013 Apr; 13(4):293-4. PubMed ID: 23538221
    [No Abstract]   [Full Text] [Related]  

  • 59. Resistance to artemisinin-based combination therapy.
    Breman JG
    Lancet Infect Dis; 2012 Nov; 12(11):820-2. PubMed ID: 22940026
    [No Abstract]   [Full Text] [Related]  

  • 60. Delayed haemolysis after artesunate therapy in a cohort of patients with severe imported malaria due to Plasmodium falciparum.
    Gómez-Junyent J; Ruiz-Panales P; Calvo-Cano A; Gascón J; Muñoz J
    Enferm Infecc Microbiol Clin; 2017 Oct; 35(8):516-519. PubMed ID: 26708338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.